Provided by Tiger Trade Technology Pte. Ltd.

BioLife Solutions

37.19
+0.09000.24%
Pre-market: 37.550.3552+0.96%04:01 EDT
Volume:548.52K
Turnover:20.34M
Market Cap:1.82B
PE:31.97
High:37.37
Open:36.81
Low:36.40
Close:37.10
52wk High:38.10
52wk Low:17.86
Shares:48.90M
Float Shares:42.68M
Volume Ratio:0.94
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.16
EPS(LYR):-0.0962
ROE:12.83%
ROA:0.26%
PB:4.33
PE(LYR):-386.50

Loading ...

Biolife Solutions Inc : Jefferies Cuts to Hold from Buy; Raises Target Price to $31 from $30

THOMSON REUTERS
·
Jul 23

HC Wainwright Downgrades BioLife Solutions to Neutral From Buy, Trims Price Target to $31 From $32

MT Newswires Live
·
Jul 23

U.S. Research Roundup-alphabet, IBM, Tesla

Reuters
·
Jul 23

France's Sartorius Stedim Biotech H1 Revenue Rises on Recurring Consumables

Reuters
·
Jul 23

Biolife Solutions Inc : Maxim Group Cuts to Hold from Buy

THOMSON REUTERS
·
Jul 23

Biolife Solutions Co May be Required to Pay Repligen Termination Fee of $59 Million, if Deal Terminates Under Certain Circumstances- SEC Filing

Reuters
·
Jul 23

TD Cowen downgrades BioLife Solutions (BLFS) to a Hold

TIPRANKS
·
Jul 23

Medpace Q2 Revenue Beats Estimates on Backlog Conversion

Reuters
·
Jul 23

Sector Update: Healthcare Stocks Softer Late Afternoon

MT Newswires Live
·
Jul 23

Maxim Downgrades BioLife Solutions to Hold From Buy

MT Newswires Live
·
Jul 23

Biolife Solutions Cut to Hold from Buy by Lake Street

Dow Jones
·
Jul 23

BioLife Solutions downgraded to Hold from Buy at Lake Street

TIPRANKS
·
Jul 22

U.S. Stocks on the Move-ge Vernova, Arrowhead Pharma

Reuters
·
Jul 22

U.S. Stocks on the Move-at&t, Cal-maine Foods, Orasure Technologies

Reuters
·
Jul 22

Shares of Biolife up 3.1% Premarket After $1.5 Billion Repligen Buyout

THOMSON REUTERS
·
Jul 22

Repligen Down 2.7%

THOMSON REUTERS
·
Jul 22

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Repligen to Buy Biolife Solutions for About USD 1.5 Billion, Offers USD 31 a Share

Reuters
·
Jul 22

Biolife Solutions - Repligen to Buy Biolife for $1.50 Bln Enterprise Value, 64% Stock, 36% Cash

THOMSON REUTERS
·
Jul 22

Biolife Solutions - Repligen Preliminary Q2 Reported Revenue Growth 12%, Organic Revenue Growth 13%

THOMSON REUTERS
·
Jul 22